Answers are grounded in this paper and cite their sources.
The NMDA receptor has been reported to be involved in opioid tolerance. Adjuvant subcutaneous infusion treatment with (very) low-dose ketamine, a NMDA receptor antagonist, improves analgesia and at the same time appears to reduce morphine tolerance. Three cases are presented.
No takes yet. Share an insight, caveat, or question.
Rae Frances Bell (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: